Long-Term Survival and Competing Causes of Death in Patients With Early-Stage Hodgkin’s Disease Treated at Age 50 or Younger PURPOSE: BRCA1 mutation carriers have a high risk of developing breast and ...

Dissemination of Information on Potentially Fatal Adverse Drug Reactions for Cancer Drugs From 2000 to 2002: First Results From the Research on Adverse Drug Events and Reports Project Purpose: To ...

SAN ANTONIO – Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing ...

The era of personalised medicine is transforming the way lung cancer is treated. By analysing the molecular characteristics of each tumour, doctors at FV Hospital can tailor treatment strategies to ...